Skip to main content

What the FDA labels say about taking them together

Fosamprenavir and ranitidine

Fosamprenavir's FDA label of September 15, 2023 names ranitidine in its drug interactions section; the ranitidine label PlainMeds reads does not name fosamprenavir. The fosamprenavir label: “Use with caution. Fosamprenavir may be less effective due to decreased amprenavir plasma concentrations.”

Check it at the source: the fosamprenavir FDA label on DailyMed (effective September 15, 2023, Mylan Pharmaceuticals Inc.); the ranitidine FDA label on DailyMed (effective May 1, 2026, Amneal Pharmaceuticals of New York LLC).

What does the fosamprenavir label say about ranitidine?

Fosamprenavir label, drug interactions

Concomitant Drug Class/Drug Name: Histamine H 2 -receptor antagonists: Cimetidine, famotidine, nizatidine, ranitidine; Effect on Concentration of Amprenavir or Concomitant Drug: Fosamprenavir: ↓ Amprenavir Fosamprenavir/ ritonavir: Interaction not evaluated; Clinical Comment: Use with caution. Fosamprenavir may be less effective due to decreased amprenavir plasma concentrations.

Source: FDA drug label (Fosamprenavir Calcium), Mylan Pharmaceuticals Inc., effective September 15, 2023 (SPL set 3a1424d8-844c-4e24-9ebd-b2c2b61b61a3), via openFDA; the full label on DailyMed

What does the ranitidine label say about fosamprenavir?

Ranitidine's label (effective May 1, 2026) does not name fosamprenavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Ranitidine), Amneal Pharmaceuticals of New York LLC, effective May 1, 2026 (SPL set b38a3332-5c54-453f-aeb7-070f830955c2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

2Fosamprenavir generic labelers
8Ranitidine generic labelers
FosamprenavirRanitidine
Labeled forHIVAcid reflux and ulcers
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?